A number of studies have analysed ovarian carcinomas for TP53 mutations, but mostly in advanced stages (Kohler et al, 1993; Kupryjanczyk et al, 1993,1995; Fallows et al, 2001; Reles et al, 2001; Leitao et al, 2002). This evidence concerns the gene TP53 and ovarian carcinoma.